Malignant tumors of the minor salivary glands. Retrospective study on 59 cases

Med Oral. 2001 Mar-Apr;6(2):142-7.
[Article in English, Spanish]

Abstract

Minor salivary glands cancer account for 2-4% of head and neck cancer, 10% of all oral cavity cancer and 15-23% of all salivary glands cancer (1). There is a remarkable variation in clinical presentation, behavior and histology of those neoplasms. The incidence of malignancy is around 52-60% (2-4) Several classifications of salivary gland tumors have been presented, but for the present study we have utilized the WHO classification of 1992 (5). We present the results of a review of our experience with those malignancies, considering prognostic factors as histopathology, tumor grade, clinical staging, age and sex, primary location, regional and distant metastasis.

MeSH terms

  • Adenocarcinoma, Clear Cell / epidemiology
  • Adenocarcinoma, Clear Cell / pathology
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Carcinoma / epidemiology*
  • Carcinoma / pathology
  • Carcinoma / secondary
  • Carcinoma, Adenoid Cystic / epidemiology
  • Carcinoma, Adenoid Cystic / pathology
  • Carcinoma, Mucoepidermoid / epidemiology
  • Carcinoma, Mucoepidermoid / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Salivary Gland Neoplasms / epidemiology*
  • Salivary Gland Neoplasms / pathology
  • Salivary Glands, Minor / pathology*
  • Sex Factors
  • Spain / epidemiology
  • Statistics as Topic
  • Survival Analysis